Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Petrelintide in Hepatic Impairment
NCT07682818Phase 1Recruiting
- Sponsor
- Zealand Pharma
- Start
- May 2026
- Primary completion
- Apr 2027
- Countries
- 2
01
Overview
Phase 1, open-label trial of petrelintide in obesity (4 arms), sponsored by Zealand Pharma. Primary endpoint: Area Under the Plasma Concentration-time Curve from Time Zero to Infinity. Started May 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07682818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682818.